The availability of direct-to-consumer genetic testing (DTCGT) for age-related macular degeneration (AMD) provides the public with access to disease risk estimations that may be used to guide lifestyle adjustments. However, AMD development risk is more complex than can be captured by gene mutations alone. The methodologies employed by current DTCGTs to estimate AMD risk vary and are limited in several ways. Genotyping-based DTCGT is biased toward European ancestry and only considers a limited number of genes. Whole genome sequencing based DTCGTs uncovers several genetic variations with unknown relevance, making risk interpretation challenging. In this perspective, we describe the limitations of the DTCGT for AMD.
de JongSGagliardiGGarantoA, et al.Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res2021; 84: 100952.
2.
Kumar-SinghR. The role of complement membrane attack complex in dry and wet AMD – from hypothesis to clinical trials. Exp Eye Res2019; 184: 266–277.
3.
ArmentoAUeffingMClarkSJ. The complement system in age-related macular degeneration. Cell Mol Life Sci2021; 78: 4487–4505.
4.
GerdesA-MNicolaisenLHusumE, et al.Direct to consumer genetic testing in Denmark—public knowledge, use, and attitudes. Eur J Hum Genet2021; 29: 851–860.
5.
RuhlGLHazelJWClaytonEW,et al.Public attitudes toward direct to consumer genetic testing. AMIA Annu Symp Proc2019; 2019: 774–783.
6.
GoldsmithLJacksonLO'ConnorA,et al.Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature. J Community Genet2013; 4: 169–180.
7.
James R. Ashenhurst JZ, Michael L. Multhaup, Ryo Kita, Olga V. Sazonova, Becca Krock, Sarah B. Laskey, Suyash Shringarpure, Nicholas A. Furlotte, 23andMe Research Team, Bertram L. Koelsch. White Paper 23-21: A Generalized Method for the Creation and Evaluation of Polygenic Scores. 2020.
DeAngelisMMOwenLAMorrisonMA, et al.Genetics of age-related macular degeneration (AMD). Hum Mol Genet2017; 26: R45–r50.
10.
OrozcoLDChenHHCoxC, et al.Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration. Cell Rep2020; 30: 1246–1259.e1246. doi:10.1016/j.celrep.2019.12.082
11.
WeiLChenPLeeJH,et al.Genetic and epigenetic regulation in age-related macular degeneration. Asia Pac J Ophthalmol (Phila)2013; 2: 269–274.
12.
BuitendijkGHAminNHofmanA, et al.Direct-to-consumer personal genome testing for age-related macular degeneration. Invest Ophthalmol Vis Sci2014; 55: 6167–6174.
13.
MaugeriABarchittaMAgodiA. The association between complement factor H rs1061170 polymorphism and age-related macular degeneration: a comprehensive meta-analysis stratified by stage of disease and ethnicity. Acta Ophthalmol2019; 97: e8–e21.
14.
KuoJZWongTYOngFS. Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy. Expert Rev Ophthalmol2013; 8: 127–140.
15.
NonyaneBASNitschDWhittakerJC, et al.An ecological correlation study of late age-related macular degeneration and the complement factor H Y402Hpolymorphism. Invest Ophthalmol Visual Sci2010; 51: 2393–2402.
16.
SmithWAssinkJKleinR, et al.Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology2001; 108: 697–704.
AgrónEMaresJClemonsTE, et al.Dietary nutrient intake and progression to late age-related macular degeneration in the age-related eye disease studies 1 and 2. Ophthalmology2021; 128: 425–442.
19.
MiddletonAMendesÁBenjaminCM,et al.Direct-to-consumer genetic testing: where and how does genetic counseling fit?Per Med2017; 14: 249–257.
20.
KainRKahnSThompsonD, et al.Database shares that transform research subjects into partners. Nat Biotechnol2019; 37: 1112–1115.
21.
ChewEYKleinMLClemonsTE, et al.Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?Ophthalmology2015; 122: 212–215.
22.
StoneEMAldaveAJDrackAV, et al.Recommendations for genetic testing of inherited eye diseases: report of the American academy of ophthalmology task force on genetic testing. Ophthalmology2012; 119: 2408–2410.
